Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Standard Biotools (LAB) Shares Issued (2016 - 2026)

Standard Biotools has reported Shares Issued over the past 16 years, most recently at $531000.0 for Q4 2025.

Quarterly Shares Issued rose 7.71% to $531000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $531000.0 through Dec 2025, down 42.16% year-over-year, with the annual reading at $531000.0 for FY2025, 42.16% down from the prior year.
Shares Issued was $531000.0 for Q4 2025 at Standard Biotools, up from -$308000.0 in the prior quarter.
Over five years, Shares Issued peaked at $980000.0 in Q2 2024 and troughed at -$627000.0 in Q3 2024.
The 5-year median for Shares Issued is $190000.0 (2024), against an average of $183083.3.
The largest YoY upside for Shares Issued was 1954.17% in 2024 against a maximum downside of 154.88% in 2024.
A 5-year view of Shares Issued shows it stood at $685000.0 in 2021, then crashed by 158.39% to -$400000.0 in 2022, then skyrocketed by 106.0% to $24000.0 in 2023, then skyrocketed by 1954.17% to $493000.0 in 2024, then rose by 7.71% to $531000.0 in 2025.
Per Business Quant, the three most recent readings for LAB's Shares Issued are $531000.0 (Q4 2025), -$308000.0 (Q3 2025), and $308000.0 (Q2 2025).